Our Products
DAPABEES M 10+500
Product Composition
Packaging Details
Product Description
DAPABEES M 10+500: Empowering Diabetic Wellness by Amcare Biosciences
Introduction
DAPABEES M 10+500 by Amcare Biosciences is an advanced dual-action diabetic care therapy designed to offer precise glycemic control and improved metabolic stability. Powered by Dapagliflozin propanediol monohydrate equivalent to Dapagliflozin 10mg and Metformin 500mg, this formulation showcases the company’s commitment to delivering high-quality and science-driven diabetic solutions. This article highlights its composition, benefits, safety profile, and Amcare Biosciences’ leadership as a leading PCD Pharma Company in Gujarat.
Composition of DAPABEES M 10+500
Dapagliflozin 10mg
An SGLT2 inhibitor that lowers blood glucose by increasing urinary glucose excretion, reducing sugar levels naturally and effectively.
Metformin 500mg
A clinically trusted biguanide that improves insulin sensitivity, reduces hepatic glucose production, and supports overall metabolic function.
Together, this dual combination makes DAPABEES M 10+500 a dependable and comprehensive therapy for Type-2 diabetic management.
Benefits and Effectiveness of DAPABEES M 10+500
Dual-Action Blood Sugar Regulation
Dapagliflozin reduces glucose reabsorption, while Metformin enhances insulin responsiveness—providing balanced and long-term glycemic control.
Promotes Weight Management & Metabolic Wellness
SGLT2 inhibitors help reduce excess glucose calories, supporting healthy weight and improved metabolism.
Reduces Risk of Hyperglycemia & Sugar Spikes
Helps maintain stable blood sugar levels throughout the day, reducing both fasting and post-meal glucose fluctuations.
Supports Kidney & Cardiovascular Health
Dapagliflozin has proven benefits in supporting kidney function and reducing cardiovascular risks in diabetic patients.
DAPABEES M 10+500 stands as a powerful, versatile, and patient-focused therapy for diabetic wellness.
Potential Side Effects – A Balanced Perspective
Most individuals tolerate DAPABEES M 10+500 well. Mild and temporary side effects may include:
-
Increased urination
-
Mild urinary tract infections
-
Gastrointestinal discomfort
-
Thirst or dehydration
Rare but serious side effects may include:
-
Kidney-related issues
-
Severe dehydration
-
Genital infections
Medical guidance is essential to ensure safe use, correct dosing, and effective monitoring. Amcare Biosciences prioritizes patient safety with responsible and high-quality diabetic care solutions.
Amcare Biosciences: Leading the Healthcare Revolution in Gujarat
Amcare Biosciences is a trusted name in Gujarat’s pharmaceutical landscape, especially known for excellence in Diabetic and Cardiac formulations. The company leads with:
-
WHO-GMP certified manufacturing
-
High-quality, clinically proven formulations
-
Ethical and transparent business practices
-
Highly rewarding PCD Pharma Franchise opportunities
DAPABEES M 10+500 reflects the company’s dedication to delivering innovative, accessible, and effective diabetic care across India.
Conclusion
DAPABEES M 10+500 by Amcare Biosciences emerges as a potent and dependable diabetic care therapy, designed to address complex glucose regulation needs with precision. With its synergistic blend of Dapagliflozin and Metformin, it supports improved sugar control, metabolic balance, and overall diabetic wellness.
As Amcare Biosciences expands its nationwide PCD Pharma network, DAPABEES M 10+500 stands as a symbol of the brand’s commitment to healthier lives and advanced diabetic solutions.